Cancer Medicine

Leukemia

20 Recent Publications

This is a list of the 20 publications most recently added to the Research Profiles database. This shows the publication activity that is ongoing at the institution.The source of publications for this application is Scopus.

  Select All    |   Export

• 1.

  2013

  Koen Van Besien; Hongtao Liu; Nitin Jain; Wendy Stock; Andrew Artz

  Umbilical cord blood transplantation supported by third-party donor cells: Rationale, results, and applications

  Biology of Blood and Marrow Transplantation. 2013;19(5):682-691.

• 2.

  2013

  Koichi Takahashi; Jorge Cortes; Sherry Pierce; Lynne Abruzzo; Hagop Kantarjian; Srdan Verstovsek

  Chromosome 5q deletion is extremely rare in patients with myelofibrosis

  Leukemia Research. 2013;37(5):552-555.

• 3.

  2013

  Alfonso Quintás-Cardama; Elias J. Jabbour

  Considerations for early switch to nilotinib or dasatinib in patients with chronic myeloid leukemia with inadequate response to first-line imatinib

  Leukemia Research. 2013;37(5):487-495.

• 4.

  2013

  Lakshmikanth Katragadda; Bing Z Carter; Gautam Borthakur

  XIAP antisense therapy with AEG 35156 in acute myeloid leukemia

  Expert Opinion on Investigational Drugs. 2013;22(5):663-670.

• 5.

  2013

  Kumudha Balakrishnan; Sumesh Aggarwal; William Wierda; Varsha Gandhi

  Bax and Bak are required for apogossypolone, a BH3-mimetic, induced apoptosis in chronic lymphocytic leukemia cells

  Leukemia and Lymphoma. 2013;54(5):1097-1100.

• 6.

  2013

  Constantine S. Tam; Michael J. Keating

  Selection of rituximab dosage in chronic lymphocytic leukemia: Where is the evidence?

  Leukemia and Lymphoma. 2013;54(5):934-939.

• 7.

  2013

  Aref Al-Kali; Alfonso Quintás-Cardama; Raja Luthra; Carlos Bueso-Ramos; Sherry Pierce; Tapan Kadia; Gautam Borthakur; Zeev Estrov; Elias Jabbour; Stefan Faderl; et al.

  Prognostic impact of RAS mutations in patients with myelodysplastic syndrome

  American Journal of Hematology. 2013;88(5):365-369.

• 8.

  2013

  J. Cortes; R. Digumarti; P.M. Parikh; M. Wetzler; J.H. Lipton; A. Hochhaus; A.R. Craig; A..-C. Benichou; F.E. Nicolini; H.M. Kantarjian

  Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors

  American Journal of Hematology. 2013;88(5):350-354.

• 9.

  2013

  Preetesh Jain; Rachel Lynn Sargent; Sergej N. Konoplev; Ohad Benjamini; Hagop Kantarjian; Tapan Kadia

  Multiple recurrent extra-medullary relapses of high-grade diffuse large B-cell lymphoma presenting in acute leukemic phase

  American Journal of Hematology. 2013;88(5):433-434.

• 10.

  2013

  Jeffrey S. Farroni; Leonard Zwelling; Jorge Cortes; Hagop Kantarjian

  Saving medicare through patient-centered changes - The case of injectables

  New England Journal of Medicine. 2013;368(17):1572-1573.

• 11.

  2013

  L. Sokol; L. Cripe; H. Kantarjian; M.A. Sekeres; S. Parmar; P. Greenberg; S.L. Goldberg; V. Bhushan; J. Shammo; R. Hohl; et al.

  Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome

  Leukemia. 2013;27(4):977-980.

• 12.

  2013

  Y. Chen; H. Kantarjian; S. Pierce; S. Faderl; S. O'Brien; W. Qiao; L. Abruzzo; M. De Lima; P. Kebriaei; E. Jabbour; et al.

  Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation

  Leukemia. 2013;27(4):836-842.

• 13.

  2013

  E.J. Freireich; B. Lichtiger; G. Mattiuzzi; F. Martinez; V. Reddy; J. Kyle Wathen

  A prospective, randomized, double-blind study, comparing unirradiated to irradiated white blood cell transfusions in acute leukemia patients

  Leukemia. 2013;27(4):861-865.

• 14.

  2013

  Alfonso Quintás-Cardama

  The role of Janus kinase 2 (JAK2) in myeloproliferative neoplasms: Therapeutic implications

  Leukemia Research. 2013;37(4):465-472.

• 15.

  2013

  Munirah Al Shuaibi; Ramez R. Bahu; Anne-Marie Chaftari; Iba Al Wohoush; William Shomali; Ying Jiang; Labib Debiane; Sammy Raad; Joseph Jabbour; Fady Al Akhrass; et al.

  Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies

  Clinical Infectious Diseases. 2013;56(7):943-950.

• 16.

  2013

  Yufeng Li; Pei Lin; Yimin Ge; Guillermo Garcia-Manero

  Myelodysplastic syndromes should been renamed as myelodysplastic neoplasms

  Leukemia Research. 2013;37(4):463-464.

• 17.

  2013

  Cesar Moncada De La Rosa; Aneta Radziwon-Balicka; Haitham El-Sikhry; John Seubert; Peter P. Ruvolo; Marek W. Radomski; Paul Jurasz

  Pharmacologic protein kinase Cα inhibition uncouples human platelet-stimulated angiogenesis from collagen-induced aggregation

  Journal of Pharmacology and Experimental Therapeutics. 2013;345(1):15-24.

• 18.

  2013

  Jorge Cortes; Eric Feldman; Karen Yee; David Rizzieri; Anjali S. Advani; Anthony Charman; Richard Spruyt; Martin Toal; Hagop Kantarjian

  Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): A randomised open-label phase 2 study

  The Lancet Oncology. 2013;14(4):354-362.

• 19.

  2013

  Naoki Shinojima; Anwar Hossain; Tatsuya Takezaki; Juan Fueyo; Joy Gumin; Feng Gao; Felix Nwajei; Frank C. Marini; Michael Andreeff; Jun-Ichi Kuratsu; et al.

  TGF-β mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells

  Cancer Research. 2013;73(7):2333-2344.

• 20.

  2013

  Ruben A. Mesa; Jason Gotlib; Vikas Gupta; John V. Catalano; Michael W. Deininger; Alan L. Shields; Carole B. Miller; Richard T. Silver; Moshe Talpaz; Elliott F. Winton; et al.

  Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: A randomized, double-blind, placebo-controlled trial

  Journal of Clinical Oncology. 2013;31(10):1285-1292.